Local ablation of pulmonary malignancies abutting pleura: Evaluation of midterm local efficacy and safety
ObjectiveTo retrospectively evaluate the efficacy and safety of local ablation treatment for adjacent pleural lung tumors.Materials and methodsSixty-two patients who underwent pulmonary nodule ablation at the Affiliated Cancer Hospital of Zhengzhou University were enrolled between January 2016 and D...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-08-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.976777/full |
| _version_ | 1828433513654779904 |
|---|---|
| author | Hong-Tao Hu Xiao-Hui Zhao Chen-Yang Guo Quan-Jun Yao Xiang Geng Wen-Bo Zhu Hong-Le Li Wei-Jun Fan Hai-Liang Li |
| author_facet | Hong-Tao Hu Xiao-Hui Zhao Chen-Yang Guo Quan-Jun Yao Xiang Geng Wen-Bo Zhu Hong-Le Li Wei-Jun Fan Hai-Liang Li |
| author_sort | Hong-Tao Hu |
| collection | DOAJ |
| description | ObjectiveTo retrospectively evaluate the efficacy and safety of local ablation treatment for adjacent pleural lung tumors.Materials and methodsSixty-two patients who underwent pulmonary nodule ablation at the Affiliated Cancer Hospital of Zhengzhou University were enrolled between January 2016 and December 2020. All patients were followed up with enhanced computed tomography or magnetic resonance imaging within 48 h after treatment and 2, 4, 6, 9, and 12 months after treatment. All patients were followed for at least 12 months.ResultsA total of 84 targeted tumors (62 patients) underwent 94 ablations. In the 12-month follow-up images, 69 of the 84 targeted tumors were completely ablated, 15 had incomplete ablation, and the 12-month incomplete ablation rate was 17.8% (15/84). Of the 15 incompletely ablated tumors, six had partial responses, five had stable disease, and four had progressive disease. The most common adverse event was pneumothorax, with an incidence of 54.8% (34/62). The second most common complication was pleural effusion, with an incidence rate of 41.9% (26/62). The incidence of needle-tract bleeding was 21% (13/62) and all patients were cured using hemostatic drugs. Serious complications were bronchopleural fistula in four patients (6.5%, 4/62) and needle tract metastasis in one patient. Four cases of bronchopleural fistula were found in the early stages and were cured after symptomatic treatment.ConclusionLocal ablation is effective for the treatment of adjacent pleural lung tumors, and its operation is safe and controllable. |
| first_indexed | 2024-12-10T18:36:40Z |
| format | Article |
| id | doaj.art-b47db09017ac4050bdf9fe4718e2e32b |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-12-10T18:36:40Z |
| publishDate | 2022-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-b47db09017ac4050bdf9fe4718e2e32b2022-12-22T01:37:47ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-08-011210.3389/fonc.2022.976777976777Local ablation of pulmonary malignancies abutting pleura: Evaluation of midterm local efficacy and safetyHong-Tao Hu0Xiao-Hui Zhao1Chen-Yang Guo2Quan-Jun Yao3Xiang Geng4Wen-Bo Zhu5Hong-Le Li6Wei-Jun Fan7Hai-Liang Li8Department of Minimal-Invasive Intervention, the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaDepartment of Minimal-Invasive Intervention, the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaDepartment of Minimal-Invasive Intervention, the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaDepartment of Minimal-Invasive Intervention, the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaDepartment of Minimal-Invasive Intervention, the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaDepartment of Minimal-Invasive Intervention, the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaThe Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaDepartment of Minimally Invasive Interventional Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaDepartment of Minimal-Invasive Intervention, the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaObjectiveTo retrospectively evaluate the efficacy and safety of local ablation treatment for adjacent pleural lung tumors.Materials and methodsSixty-two patients who underwent pulmonary nodule ablation at the Affiliated Cancer Hospital of Zhengzhou University were enrolled between January 2016 and December 2020. All patients were followed up with enhanced computed tomography or magnetic resonance imaging within 48 h after treatment and 2, 4, 6, 9, and 12 months after treatment. All patients were followed for at least 12 months.ResultsA total of 84 targeted tumors (62 patients) underwent 94 ablations. In the 12-month follow-up images, 69 of the 84 targeted tumors were completely ablated, 15 had incomplete ablation, and the 12-month incomplete ablation rate was 17.8% (15/84). Of the 15 incompletely ablated tumors, six had partial responses, five had stable disease, and four had progressive disease. The most common adverse event was pneumothorax, with an incidence of 54.8% (34/62). The second most common complication was pleural effusion, with an incidence rate of 41.9% (26/62). The incidence of needle-tract bleeding was 21% (13/62) and all patients were cured using hemostatic drugs. Serious complications were bronchopleural fistula in four patients (6.5%, 4/62) and needle tract metastasis in one patient. Four cases of bronchopleural fistula were found in the early stages and were cured after symptomatic treatment.ConclusionLocal ablation is effective for the treatment of adjacent pleural lung tumors, and its operation is safe and controllable.https://www.frontiersin.org/articles/10.3389/fonc.2022.976777/fulllung malignanciesmicrowave ablationradiofrequency ablationpleuracryoablation, |
| spellingShingle | Hong-Tao Hu Xiao-Hui Zhao Chen-Yang Guo Quan-Jun Yao Xiang Geng Wen-Bo Zhu Hong-Le Li Wei-Jun Fan Hai-Liang Li Local ablation of pulmonary malignancies abutting pleura: Evaluation of midterm local efficacy and safety Frontiers in Oncology lung malignancies microwave ablation radiofrequency ablation pleura cryoablation, |
| title | Local ablation of pulmonary malignancies abutting pleura: Evaluation of midterm local efficacy and safety |
| title_full | Local ablation of pulmonary malignancies abutting pleura: Evaluation of midterm local efficacy and safety |
| title_fullStr | Local ablation of pulmonary malignancies abutting pleura: Evaluation of midterm local efficacy and safety |
| title_full_unstemmed | Local ablation of pulmonary malignancies abutting pleura: Evaluation of midterm local efficacy and safety |
| title_short | Local ablation of pulmonary malignancies abutting pleura: Evaluation of midterm local efficacy and safety |
| title_sort | local ablation of pulmonary malignancies abutting pleura evaluation of midterm local efficacy and safety |
| topic | lung malignancies microwave ablation radiofrequency ablation pleura cryoablation, |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2022.976777/full |
| work_keys_str_mv | AT hongtaohu localablationofpulmonarymalignanciesabuttingpleuraevaluationofmidtermlocalefficacyandsafety AT xiaohuizhao localablationofpulmonarymalignanciesabuttingpleuraevaluationofmidtermlocalefficacyandsafety AT chenyangguo localablationofpulmonarymalignanciesabuttingpleuraevaluationofmidtermlocalefficacyandsafety AT quanjunyao localablationofpulmonarymalignanciesabuttingpleuraevaluationofmidtermlocalefficacyandsafety AT xianggeng localablationofpulmonarymalignanciesabuttingpleuraevaluationofmidtermlocalefficacyandsafety AT wenbozhu localablationofpulmonarymalignanciesabuttingpleuraevaluationofmidtermlocalefficacyandsafety AT hongleli localablationofpulmonarymalignanciesabuttingpleuraevaluationofmidtermlocalefficacyandsafety AT weijunfan localablationofpulmonarymalignanciesabuttingpleuraevaluationofmidtermlocalefficacyandsafety AT hailiangli localablationofpulmonarymalignanciesabuttingpleuraevaluationofmidtermlocalefficacyandsafety |